1. A randomized, double-blind study on efficacy and safety of sepranolone in premenstrual dysphoric disorder. (November 2021) Authors: Bäckström, Torbjörn; Ekberg, Karin; Hirschberg, Angelica Lindén; Bixo, Marie; Epperson, C. Neill; Briggs, Paula; Panay, Nick; O'Brien, Shaughn Journal: Psychoneuroendocrinology Issue: Volume 133(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. C-Peptide and Its C-Terminal Fragments Improve Erythrocyte Deformability in Type 1 Diabetes Patients. (6th May 2008) Authors: Hach, Thomas; Forst, Thomas; Kunt, Thomas; Ekberg, Karin; Pfützner, Andreas; Wahren, John Other Names: Chakrabarti Subrata Academic Editor. Journal: Experimental diabetes research Issue: Volume 2008(2008) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Treatment of premenstrual dysphoric disorder with the GABAA receptor modulating steroid antagonist Sepranolone (UC1010)—A randomized controlled trial. (June 2017) Authors: Bixo, Marie; Ekberg, Karin; Poromaa, Inger Sundström; Hirschberg, Angelica Lindén; Jonasson, Aino Fianu; Andréen, Lotta; Timby, Erika; Wulff, Marianne; Ehrenborg, Agneta; Bäckström, Torbjörn Journal: Psychoneuroendocrinology Issue: Volume 80(2017) Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗